# Indalo Therapeutics: Biotechnology, Cambridge, United States

> Indalo Therapeutics: Indalo Therapeutics, Inc. Based in Cambridge, United States. Founded 2014. What Millionrounds holds on them, and what we have not seen.

Source: https://millionrounds.com/startup/indalo-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Indalo Therapeutics

Indalo Therapeutics, Inc.

Funding reported Last round: Venture (Round not Specified)

Biotechnology Cambridge, United States

Company summary

- **Founded:** 2014 12 years old
- **Team:** 3 1 to 10 people
- **Funding reported:** $12M in dollars
- **Last round:** Venture (Round not Specified) Apr 2020

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Indalo Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Indalo Therapeutics

Indalo Therapeutics, Inc.

is a preclinical-stage biopharmaceutical company established in 2016 through the merger of Antegrin Therapeutics LLC and Cascadian Therapeutics, Inc. The company is focused on developing integrin antagonist therapies for serious fibrotic diseases, including nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). Headquartered primarily in St. Louis, Missouri, Indalo emphasizes its experienced team and strong intellectual property. The company's lead candidate, IDL-2965, is an oral small molecule antagonist that targets specific integrins to inhibit various stages of pathologic fibrosis. This candidate has advanced to Phase 2 trials for NASH and related fibrotic conditions. Indalo Therapeutics has raised significant funding to support its development efforts, showcasing a commitment to improving outcomes for patients with debilitating fibrotic diseases.

## What company datasets say Indalo Therapeutics raised

Funding, as reported

Reported in all **$12M** in dollars

Last round **Venture (Round not Specified)**

Last round size **$2.0M**

Last round date **Apr 2020**

## Founders and team

From the SEC filings it signed: 3 on the team.

- **Bradford H. Williamson** Executive Officer i
- **George H. Capps** Executive Officer, Promoter i
- **Scott H. Seiwert** Executive Officer i

On the board, as filed i *Ben H. Auspitz* *Peter H. Barrett* *Rajesh H. Devraj*

## The company, in detail

What they build

Known for

health care broad target profiles fibrosis drug development small molecule drugs fibrotic disease therapies hospital & health care medical fibrosis at its core health biotechnology fibrosis research tools integrin inhibitors research and development in the physical integrin-selective small molecules tgf-activation engineering

Built with from their website

CloudFlare CloudFlare CDN Cloudflare DNS

- **Sector:** Biotechnology
- **Industry code:** NAICS 54171, SIC 2834
- **Region:** Massachusetts
- **Revenue:** $5.0M a year, as listed

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put Indalo Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)